Botanical and Plant Derived Drugs Market Size, Share, Analysis Report

Botanical and Plant Derived Drugs Market By Product (Tablets, Capsules, Pills, Injections); By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and by Regional Analysis - Global Forecast by

The Botanical and Plant Derived Drugs Market is expected to be around US$ 47.40 Billion by 2028 at a CAGR of 6% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Abbott Laboratories
  • Bayer Healthcare
  • Bionova
  • Bristol Myers
  • Curapharm
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    6

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Botanical drugs are those medications which are derived from therapeutic plants. Plant determined medications are blend of plant and other affirmed sedates that contains plant materials, synthetic and semi manufactured substances. Botanical drugs comprise of vegetable material, green growth and plainly visible organisms. They are utilized in treatment of different diseases, for example cardiovascular sicknesses, different central nervous system disorders, irresistible infections and respiratory illnesses.  Botanical drugs are available in various forms, for example, tablets, pills, injections and capsules.

    How Big is The Botanical and Plant Derived Drugs Market?

    The Botanical and Plant Derived Drugs Market is expected to be around US$ 47.40 Billion by 2028 at a CAGR of 6% in the given forecast period.

    The major driving factors of Botanical and Plant Derived Drugs Market are as follows:

    • Rise in usage of botanical drugs as an alternative to synthetic medicine
    • Technological advancement in production procedure and low cost of botanical drugs
    • Growing prevalence of various chronic diseases

    The major restraining factors of Botanical and Plant Derived Drugs Market are as follows:

    • Strict laws and regulations for approval of botanical drugs
    • Low acceptance of these drugs for the treatment of lethal diseases

    The major opportunities of Botanical and Plant Derived Drugs Market are as follows:

    • Increasing number of FDA approved botanical drugs and their application

    The Botanical and Plant Derived Drugs Market has been segmented as below:

    By Product:

    • Tablets
    • Capsules
    • Pills
    • Injections

    By Application:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores

    By Regional Analysis:

    •     North America
    •     Europe
    •     Asia-Pacific
    •     Rest of the World

    The Botanical and Plant Derived Drugs Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covers as tablets, capsules, pills and injections. Based on application classification it includes hospital pharmacies, retail pharmacies, online pharmacies and drug stores. The Botanical and Plant Derived Drugs Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:

    1) An overview of the global market for Botanical and Plant Derived Drugs Market and related technologies
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Botanical and Plant Derived Drugs Market.

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry. 

    Report Scope:

    The scope of the report includes a detailed study of Botanical and Plant Derived Drugs Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    Reasons to Buy this Report:

    1. Obtain the most up to date information available on all Botanical and Plant Derived Drugs Market.
    2. Identify growth segments and opportunities in the industry.
    3. Facilitate decision making on the basis of strong historic and forecast of Botanical and Plant Derived Drugs Market.
    4. Assess your competitor’s refining portfolio and its evolution.

    Customization:

    We can offer you custom research reports as per client’s special requirements.

    Below are our New Reports :-

    curcumin market

    pharmacovigilance market

    Latin America excipients market

    Drug Discovery Services Market

    Herbal Bitters Market

    1.    Introduction
        1.1    Report Description
        1.2    Markets Covered
        1.3    Stakeholders

    2.    Research Methodology
        2.1    Research Data
        2.2    Market Size Estimation and Data Triangulation
        2.3    Research Assumptions

    3.    Report Summary

    4.    Market Overview
        4.1    Introduction
        4.2    Drivers
        4.3    Restrains
        4.4    Industry Trends
        4.5    Porter’s Five Forces Analysis

    5.    Botanical and Plant Derived Drugs Market Analysis, By Product
        5.1    Tablets
        5.2    Capsules
        5.3    Pills
        5.4    Injections

    6.    Botanical and Plant Derived Drugs Market Analysis, By Application
        6.1    Hospital Pharmacies
        6.2    Retail Pharmacies
        6.3    Online Pharmacies
        6.4    Drug Stores

    7.    Botanical and Plant Derived Drugs Market Analysis, By Region
        7.1    North America
        7.2    Europe
        7.3    Asia-Pacific
        7.4    Rest of the World

    8.    Competitive Overview
        8.1    Introduction
        8.2    New Product Launches
        8.3    Acquisitions
        8.4    Agreements, Partnerships, And Collaborations
        8.5    Expansions

    9.    Company Profiles
        9.1    Abott Laboratories
        9.2    Bayer Healthcare
        9.3    Bionova
        9.4    Bristol Myers
        9.5    Curapharm

    The Botanical and Plant Derived Drugs Market has been segmented as below:

    By Product:

    • Tablets
    • Capsules
    • Pills
    • Injections

    By Application:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores

    By Regional Analysis:

    •     North America
    •     Europe
    •     Asia-Pacific
    •     Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 6% during the study period (2023-2028)
    The Botanical and Plant Derived Drugs Market is expected to be around US$ 47.40 Billion by 2028
    The segment included in the Botanical and Plant Derived Drugs Market is Product, Application and region.
    Some key players operating in the Botanical and Plant Derived Drugs Market include Abbott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports